Concert Pharmaceuticals Alpha and Beta Analysis
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Concert Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Concert Pharmaceuticals over a specified time horizon. Remember, high Concert Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Concert Pharmaceuticals' market risk premium analysis include:
Beta 1.41 | Alpha 0.71 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Concert |
Concert Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Concert Pharmaceuticals market risk premium is the additional return an investor will receive from holding Concert Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Concert Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Concert Pharmaceuticals' performance over market.| α | 0.71 | β | 1.41 |
Concert Pharmaceuticals Fundamentals Vs Peers
Comparing Concert Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Concert Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Concert Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Concert Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Concert Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Concert Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Concert Pharmaceuticals to competition |
| Fundamentals | Concert Pharmaceuticals | Peer Average |
| Return On Equity | -1.09 | -0.31 |
| Return On Asset | -0.39 | -0.14 |
| Operating Margin | (2.88) % | (5.51) % |
| Current Valuation | 86.63 M | 16.62 B |
| Shares Outstanding | 48.02 M | 571.82 M |
| Shares Owned By Insiders | 3.77 % | 10.09 % |
| Shares Owned By Institutions | 77.05 % | 39.21 % |
Concert Pharmaceuticals Opportunities
Concert Pharmaceuticals Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Indias Sun Pharma beats Q3 profit view on higher sales of specialty drugs | 01/31/2023 |
2 | Harvest Investment Services LLC Makes New 282,000 Investment in Concert Pharmaceuticals, Inc. | 02/08/2023 |
3 | CNCE Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders | 02/13/2023 |
4 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates CNCE, ISO, TIG | 02/15/2023 |
About Concert Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Concert or other delisted stocks. Alpha measures the amount that position in Concert Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Concert Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Concert Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Concert Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Concert Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Concert Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Concert Pharmaceuticals' management manipulating its earnings.
| 2nd of March 2023 Upcoming Quarterly Report | View | |
| 4th of May 2023 Next Financial Report | View | |
| 31st of December 2022 Next Fiscal Quarter End | View | |
| 2nd of March 2023 Next Fiscal Year End | View | |
| 30th of September 2022 Last Quarter Report | View | |
| 31st of December 2021 Last Financial Announcement | View |
Build Portfolio with Concert Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |